CD8A and lymphopenia: Overall, exhibiting low levels of T-cell activation seems to be associated to a better disease outcome, as described in (9); on the other hand, exhibiting profound CD8+ T-cell lymphopenia, a high level of CD4+ and CD8+ T-cell activation and a high level of CD8+ T-cell senescence seems to be globally associated with a higher mortality outcome.